scPharmaceuticals
SCPH
SCPH was delisted on the 6th of October, 2025.
38 hedge funds and large institutions have $75.9M invested in scPharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 3 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 10
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
3% more funds holding
Funds holding: 37 → 38 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.69% less ownership
Funds ownership: 58.03% → 57.34% (-0.69%)
16% less capital invested
Capital invested by funds: $90.1M → $75.9M (-$14.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$13.4M |
| 2 |
Belvedere Trading
Chicago,
Illinois
|
+$388K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
+$182K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$158K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$77.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$15.1M |
| 2 |
5VM
5AM Venture Management
San Francisco,
California
|
-$1.34M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$426K |
| 4 |
JGC
J. Goldman & Co
New York
|
-$383K |
| 5 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$247K |
SCPH Hedge Fund Activity: Q2 2022 in Review
38 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in scPharmaceuticals (SCPH) for Q2 2022, worth a combined $75.9M — down 16% from $90.1M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new SCPH positions and 3 closed out — a net gain of 1 holder — while 16 added to existing stakes and 10 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $13.4M. The largest seller was RA Capital Management, exiting entirely with an estimated $15.1M sold.
- 38 institutional investors held scPharmaceuticals (SCPH) as of Q2 2022, up from 37 in Q1 2022.
- Funds reported $75.9M of scPharmaceuticals stock for Q2 2022, down 16% quarter-over-quarter.
- 4 funds opened new scPharmaceuticals positions in Q2 2022 and 3 closed out, a net change of +1 holder.
- The largest scPharmaceuticals buyer in Q2 2022 was Armistice Capital, an estimated $13.4M added.
- The largest scPharmaceuticals seller in Q2 2022 was RA Capital Management, an estimated $15.1M sold.
Based on aggregated 13F filings for Q2 2022.